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Abstract
The rearrangement of intracellular membranes has been long reported to be a common feature in diseased cells. In this
study, we used dengue virus (DENV) to study the role of the unfolded protein response (UPR) and sterol-regulatory-
element-binding-protein-2 (SREBP-2) pathway in the rearrangement and expansion of the endoplasmic reticulum (ER) early
after infection. Using laser scanning confocal and differential interference contrast microscopy, we demonstrate that
rearrangement and expansion of the ER occurs early after DENV-2 infection. Through the use of mouse embryonic fibroblast
cells deficient in XBP1 and ATF6, we show that ER rearrangement early after DENV infection is independent of the UPR. We
then demonstrate that enlargement of the ER is independent of the SREBP-2 activation and upregulation of 3-hydroxy-3-
methylglutaryl-Coenzyme-A reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway. We further show
that this ER rearrangement is not inhibited by the treatment of DENV-infected cells with the cholesterol-inhibiting drug
lovastatin. Using the transcription inhibitor actinomycin D and the translation elongation inhibitor cycloheximide, we show
that de novo viral protein synthesis but not host transcription is necessary for expansion and rearrangement of the ER.
Lastly, we demonstrate that viral infection induces the reabsorption of lipid droplets into the ER. Together, these results
demonstrate that modulation of intracellular membrane architecture of the cell early after DENV-2 infection is driven by viral
protein expression and does not require the induction of the UPR and SREBP-2 pathways. This work paves the way for
further study of virally-induced membrane rearrangements and formation of cubic membranes.
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Introduction
Dengue virus (DENV) causes tens of millions of cases of dengue
annually and is a major international health concern. DENV is a
small, enveloped, positive-sense RNA virus that encodes ten viral
proteins – three structural proteins (C, prM/M and E) and seven
nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B and NS5). DENV and other members of the Flaviviridae
family are endoplasmic reticulum (ER)-tropic viruses that are
dependent on the host ER to translate, replicate and package their
genome [1]. Infection with DENV, as well as other members of
the Flaviviridae family, has been shown to induce rearrangement of
cellular membranes known as cubic membranes (often described
as convoluted membranes and vesicle packets that contain the
replication complex) [2,3,4]. Recent studies of DENV-2 [5] and
WNVKun [6] using electron tomography revealed the three-
dimensional composition of these virally-induced structures to be a
network of ER-derived membranes.
The ER is an extensive membranous network that is contiguous
with the nuclear membrane and is responsible for the synthesis,
maturation and proper folding of a wide range of proteins. It also
plays a critical role in Ca
2+ and lipid homeostasis as well as
intracellular signal transduction. When the capacity of the ER to
handle client proteins entering the ER is exceeded, this leads to the
induction of inter-organelle signaling pathways that respond to ER
stress by coordinately regulating translation and gene expression
through an elaborate adaptive response known as the unfolded
protein response [7]. The unfolded protein response (UPR)
functions through the PKR-like ER kinase (PERK), kinase/
endoribonuclease inositol requiring 1 (IRE1)/X-box binding
protein 1 (XBP1), and/or activation transcription factor 6
(ATF6) pathways. Activation of the UPR slows the flow of nascent
proteins entering the ER and allows for the coordinated
upregulation of genes involved in maintaining ER homeostasis
[7,8,9,10]. Activation of transcription factors XBP1 and ATF6 has
been recently linked to ER biogenesis, indicating that the UPR can
also expand and increase the size of the ER [11,12,13,14]. Despite
the UPR’s protective role, prolonged and persistent ER stress can
result in caspase activation and cellular apoptosis [15].
Additionally, the ER houses the sterol regulatory element-
binding protein (SREBP) sensors that are important for maintain-
ing cholesterol and lipid metabolism through the SREBP pathway
[16]. SREBPs are ER membrane-associated transcription factors
and include SREBP-1 and SREBP-2. SREBP-1 consists of two
isoforms, SREBP-1a and SREBP-1c, due to alternative splicing.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38202SREBP-1 is involved in the biosynthesis of cholesterol and fatty
acids, while SREBP-2 primarily mediates cholesterol biosynthesis
[17]. SREBP proteins are maintained in an inactive state via
association with SREBP-cleavage-activating protein (Scap), which
functions as a sterol sensor, and another ER-associated protein,
insulin-induced gene (Insig). When ER membranes are depleted of
cholesterol, Scap escorts SREBP from the ER to the Golgi, where
it is proteolytically processed and activated [16,18,19,20]. Tran-
scriptionally active SREBPs also enhance their own transcription
through a feed-forward mechanism that is dependent on the
amount of cholesterol present in the cell [21].
The rearrangement and formation of virally-induced membrane
structures have been reported for DENV and various positive-
strand RNA viruses [2,3,4,22,23,24,25]. However, despite our
improved understanding of the composition and three dimensional
architecture of these structures, how they are formed, the
requirements for their formation, the involvement of viral and
host factors, and the induction of cellular pathways involved in
lipid and ER biogenesis are still not well defined. In these studies,
we investigate which cellular pathways are involved in the
rearrangement and expansion of the ER early after DENV-2
infection by examining cellular pathways previously reported to
induce lipid and ER membrane biogenesis. Recently, we reported
the time-dependent activation of the UPR during a DENV-2
infection [26]. Here, through the use of high-resolution laser
scanning confocal microscopy and differential interference mi-
croscopy, we show that DENV induces rearrangement and
expansion of the ER early after infection independently of the
UPR or SREBP2 pathways. Rather, the gross enlargement of the
ER early in DENV-2 infection appears to be driven by the
expression of viral proteins, causing the rearrangement of the
preexisting ER membranous network and the reabsorption of lipid
droplets (LDs).
Results
Dengue Virus Induces ER Expansion Early After Infection
We began investigating ER expansion early after DENV-2
infection by testing two hypotheses. The first posits that the
rearrangement and expansion of the ER leads to the concentration
of resident ER proteins within the enlarged ER without inducing
increased transcription and/or translation of resident ER proteins
or additional membrane biogenesis. Alternatively, the second
hypothesis is that the rearrangement and expansion of the ER
early during DENV-2 infection requires the induction of pathways
involved in lipid and ER biogenesis. To evaluate the role of the
UPR in ER expansion early after DENV-2 infection, we first
stained cellular proteins ATF6 and XBP1 in uninfected human
2fTGH cells that were mock-treated (Figure S1 A) or treated with
DTT (Figure S1 B), a potent ER stress inducer. Consistent with
our previous results, we found that UPR induction using DTT
leads to the activation and nuclear localization of XBP1 and ATF6
(Figure S1 B) [26]. Next, we mock-treated or treated uninfected
2fTGH cells with the ER stress-inducing drug thapsigargin for 12
hours (h) to mimic persistent ER stress and trigger the
upregulation of the resident ER chaperone proteins GRP78 and
GRP94. Under these conditions, we demonstrate that GRP78
(Figure S1 C) is strongly induced; however, induction of GRP94 is
minimal (Figure S1 D), compared to mock-treated cells (Fig. 1E
and 1F; respectively). As a negative control for viral infection, we
also stained uninfected and mock-treated 2fTGH cells for DENV
E and NS3, and as expected, no staining was observed (Fig. 1A
and Figure S1 C and D).
Having shown the specificity and cellular distribution of these
UPR markers, we proceeded to test our two hypotheses. We
previously demonstrated the induction of the IRE1-XBP1
pathway 12–36 h post-infection (p.i) and the transient activation
of the ATF6 pathway late in DENV-2 infection [26]. Here, we
focused on a very early time-point, 12 h p.i. Through the use of
laser scanning confocal microscopy (LSCM) and differential
interference contrast (DIC) microscopy, we show the ER-resident
chaperone proteins GRP78 (Fig. 1B) and GRP94 (Fig. 1C) to be
localized within an enlarged ER in DENV-2-infected 2fTGH cells
at 12 h p.i. These ER-resident chaperone proteins colocalize with
DENV-2 viral proteins E and NS3 within a grossly enlarged ER
that is visible using DIC imaging (Fig. 1B, C, D, E). This gross
alteration of the ER is absent in mock-infected 2fTGH cells
(Fig. 1A), neighboring uninfected cells (Fig. 1B and 1C), and
thapsigargin (Tg)-treated cells (Figure S1 C and D).
In our previous studies, we demonstrated that Xbp1 mRNA
splicing began 12 h after DENV-2 infection [26]. Based on these
observations, we next wanted to determine whether the activation
of the IRE1-XBP1 pathway was driving the rearrangement and
expansion of the ER at this early time-point during a DENV-2
infection. When we stained DENV-2-infected 2fTGH cells for
XBP1, we found XBP1 to be expressed; however, it co-localized
with NS3 and E within the enlarged ER (Fig. 1D) and not in the
nucleus, as demonstrated in our DTT activation control (Figure S1
B). Additionally, we wanted to show that the ATF6 pathway was
not induced at 12 h p.i. Using an N-terminus-specific anti-ATF6
antibody that recognizes the cytosolic portion of ATF6, we
demonstrated that activation of the ATF6 pathway is not induced,
as it remained localized to the ER and did not translocate to the
nucleus (Fig. 1E), again consistent with our previous results [26].
The observation that both ER-resident proteins GRP78 and
GRP94 in DENV-2-infected 2fTGH were colocalized to the ER
with viral proteins E and NS3 in the absence of XBP1 or ATF6
nuclear localization suggested that ER rearrangement and
expansion during DENV-2 infection proceeded independently of
the UPR. However, it has been demonstrated that GRP78
contains an IRES element that allows for increased translation
without inducing transcriptional activation [27,28]; therefore, we
investigated whether GRP78 expression was upregulated early
during a DENV-2 infection. When we infected 2fTGH cells with
DENV-2 at an MOI of 5 for a 3–12 h time-course and analyzed
the lysates by immunoblot for levels of GRP78, we found no
difference in protein levels in DENV-2-infected cells compared to
mock-infected cells (Fig. 1F); this observation is also consistent with
our previous findings [26]. These results suggest that DENV leads
to the rearrangement and expansion of the ER early after infection
and that the fluorescence increase we observed in the ER results
from the relocalization and concentration of GRP78 and GRP94
within the expanded ER without de novo protein synthesis.
DENV-2 Induces ER Expansion in a UPR-independent
Manner Early in Infection
Previous studies have shown XBP1 to play a critical role in cell
size expansion, organelle biogenesis, increased protein synthesis,
and induction of secretory genes [11,13,14,29]. In Fig. 1, we
presented data that suggests that DENV-induced rearrangement
and expansion of the ER is independent of the UPR. To further
demonstrate that this ER rearrangement is independent of the
XBP1 pathway, we infected XBP1
+/+ and XBP1
2/2 mouse
embryo fibroblast (MEF) cells with DENV-2 for 12 h and fixed
and processed them for LSCM analysis. As demonstrated with
2fTGH cells (Fig. 1), we found that ER-resident proteins GRP78
and GRP94 co-localize with E and NS3 proteins within the
ER Rearrangement by DENV-2 Early after Infection
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38202Figure 1. DENV induces rearrangement of the ER early after infection. 2fTGH cells were (A) mock-infected or (B–E) infected with DENV-2 for
12 h and stained intracellularly for UPR markers and viral proteins E and NS3. (A) Mock-infected 2fTGH cells were stained with mouse MAbs against
DENV E (4G2; green) and NS3 (E1D8; red) directly conjugated to Alexa FluorH 488 and Alexa FluorH 594, respectively. Nuclear staining (blue) was
performed using DAPI stain. Intracellular staining of DENV-infected cells was carried out as in (A); in addition primary antibodies specific for cellular
proteins (B) GRP78, (C) GRP94, (D) XBP1 and (E) ATF6 (magenta) were used, followed by secondary antibodies conjugated to Alexa FluorH 647. The
multiple-exposure images were captured using 63X/1.25 Plan-Neofluar DIC oil objective on Zeiss 510 LSM using bandpass filter sets appropriate for
DAPI, Alexa FluorH 488, Alexa FluorH 594 and Alexa FluorH 647. For individual images, the additional channels were turned OFF post-acquisition using
the Zeiss operating software. Co-localization is observed in the ‘‘Merged’’ image as a yellow hue. Merged and DIC images represent a single image
with all detector channels ON. Total magnification 6306. (F) Western blot analysis of GRP78 over a 12-h course of DENV infection. Actin was used as a
loading control, and expression of DENV NS1 was used to confirm viral infection.
doi:10.1371/journal.pone.0038202.g001
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+/+ (Fig. 2A and 2B) and
XBP1
2/2 (Fig. 2E and 2F) MEF cells. As expected, XBP1 is
visible in DENV-2-infected XBP1
+/+ MEF cells (Fig. 2C) where
we again find it colocalized with E and NS3 in the ER, but it is not
detected in XBP1
2/2 MEF cells (Fig. 2G). A recent study
demonstrated that the ATF6 pathway can induce expansion and
upregulation of pathways involved in lipid biosynthesis and ER
biogenesis in XBP1
2/2 MEFs [12]. When we examined the
activation of the ATF6 pathway in both XBP1
+/+ (Fig. 2D) and
XBP1
2/2 (Fig. 2H) MEF cells, we found that ATF6 remains
uninduced and localized to the ER of DENV-2-infected cells, also
consistent we our previous results [26].
To further demonstrate that rearrangement and expansion of
the ER is ATF6-independent early after DENV-2 infection, we
infected ATF6
+/+ and ATF6
2/2 MEF cells with DENV-2, fixed
them, and processed them for LSCM 12 h p.i. Consistent with the
data in Fig. 1, we once again found expression of GRP78 (Fig. 3A
and 3D) and GRP94 (Fig. 3B and 3E) to localize within a
rearranged and enlarged ER in DENV-2-infected ATF6
+/+ and
ATF6
2/2 MEF cells. Furthermore, expression of DENV E and
NS3 proteins was co-localized with GRP78 and GRP94 in the
expanded ER. In addition, the expression of XBP1 is induced but
remains localized to the ER in both ATF6
+/+ (Fig. 3C) and
ATF6
2/2 (Fig. 3F) MEF cells. These data show that rearrange-
ment and expansion of the ER early during DENV-2 infection is
independent of the ATF6 and IRE1/XBP1 pathways of the UPR.
DENV-2 Induces ER Expansion in an SREBP-2-
independent Manner
SREBP-2 has been shown to regulate both lipid and cholesterol
synthesis in vivo and in vitro [30,31,32]. Therefore, we next
investigated whether DENV-2 infection led to activation of the
SREBP-2 pathway and induction of 3-hydroxy-3-methylglutaryl-
Coenzyme A reductase (HMGCR), the rate-limiting enzyme
involved in cholesterol biosynthesis. We first mock-treated or
DTT-treated 2fTGH cells for 6 h to induce ER stress and stained
for cellular distribution of SREBP-2 and HMGCR. Mock-treated
2fTGH cells demonstrated diffused staining of SREBP-2 through-
out the cell, while low levels of HMGCR were detected around the
nucleus (Fig. 4A). This contrasts with DTT-treated 2fTGH cells
(Fig. 4B), which demonstrated activation of SREBP-2 by increased
nuclear localization and increased expression of HMGCR around
the nucleus. We next determined whether rearrangement of the
ER during DENV-2 infection was driven by the activation of
SREBP-2 and upregulation of HMGCR in infected cells. We
infected 2fTGH cells with DENV-2 at an MOI of 5 for 12 h, fixed
and stained the cells, and determined whether the SREBP-2
pathway was activated and expression of HMGCR upregulated.
SREBP-2 staining of DENV-2-infected 2fTGH cells (Fig. 4C)
demonstrated that SREBP-2, like ATF6, remained inactive and
localized to the ER with E and NS3 viral proteins. HMGCR was
redistributed to the enlarged ER in DENV-2-infected cells
compared to its nuclear distribution in uninfected cells (Fig. 4D).
To further demonstrate that early DENV-2 infection did not
lead to the activation of the SREBP-2 pathway, we mock-treated
or DTT-treated 2fTGH cells for 6 h, harvested lysates, and
processed them by immunoblot to monitor proteolytic processing
of the precursor SREBP-2 (pSREBP-2). As shown in Figure 4E,
cells that were treated with DTT displayed lower levels of
pSREBP-2 than mock-treated cells, consistent with previously
published results [33]. We next mock-infected these cells or
infected them with DENV-2 and carried out a 3–12 h course of
infection. Cells were harvested at the indicated time-points, and
lysates were processed for immunoblot. As shown in Figure 4F,
levels of pSREBP-2 in DENV-2-infected cells were not reduced
compared to the time-matched mock-infected controls, and levels
of HMGCR remained essentially unchanged. To demonstrate that
cells were infected, we probed for viral NS1 protein expression.
Together, these data show that rearrangement and expansion of
the ER early during DENV-2 infection proceeds independently of
SREBP-2 activation and induction of HMGCR. Previous studies
have demonstrated HMGCR to be synthesized and localized to
the outer nuclear membrane [34]. Our data demonstrate the
cellular redistribution of HMGCR to the ER with E and NS3 viral
proteins, consistent with previous results for WNVkun [35] and
suggest a potential involvement of the outer nuclear membrane in
the enlargement and expansion of the ER during DENV infection.
Lovastatin Inhibits Production of Infectious Virus but not
ER Rearrangement and Expansion
Our studies thus far have demonstrated that DENV-2 infection
leads to early rearrangement and expansion of the ER that is
independent of the UPR and SREBP-2 pathways. However,
recent studies on WNVkun, JEV, and DENV have shown
cholesterol to play an important role in viral entry, replication
and immune evasion [35,36,37,38]. Thus, we next evaluated
whether treatment of 2fTGH cells with lovastatin, a cholesterol
inhibitor, prevented the rearrangement of the ER in cells infected
with DENV-2. To test this, we first mock-treated or lovastatin-
treated 2fTGH cells for 12 h. Cells were fixed and stained for
SREBP-2 and HMGCR and analyzed by LSCM and DIC.
Treatment of mock-infected 2fTGH cells with 10 mM lovastatin
did not lead to activation of SREBP-2 or upregulation of
HMGCR (Fig. 5A), nor to the rearrangement and expansion of
the ER. Staining for DENV E and NS3 was negative, as expected
(Fig. 5B). We then tested whether lovastatin inhibited DENV-2-
induced ER expansion. 2fTGH cells were mock-infected or
infected with DENV-2 at an MOI of 5 for 12 h in the presence or
absence of 10 mM lovastatin at the time of infection. Cells were
fixed and stained for SREBP-2 and HMGCR as well as for viral
proteins E and NS3. As with our previous results, we demonstrated
that DENV-2 infection leads to the rearrangement and expansion
of the ER (Fig. 5C and 5D). Also, SREBP-2 (Fig. 5C) and
HMGCR (Fig. 5D) co-localized to the enlarged ER with E and
NS3 as previously shown in Fig. 4. The treatment of DENV-2-
infected 2fTGH cells with 10 mM lovastatin at the time of DENV-
2 infection did not lead to the activation of the SREBP-2 pathway
(Fig. 5E) or upregulation of HMGCR (Fig. 5F). Moreover, the
treatment of DENV-2-infected cells with lovastatin did not inhibit
the rearrangement and expansion of the ER (Fig. 5E and 5F).
TheobservationthatlovastatindidnotinhibitDENV-inducedER
rearrangementwasaninterestingfindinggiventhatpreviousstudies
have demonstrated lovastatin to inhibit infectious virus production.
WenexttestedwhetherlovastatininhibitedDENV-2infectiousvirus
production in our 2fTGH system [38]. We carried out a 24–48 h
courseofinfectioninwhich2fTGHcellswereinfectedwithDENV-2
atanMOIof5inthepresenceorabsenceofincreasingconcentrations
oflovastatin.AsdemonstratedinFigureS2,productionofinfectious
virusdecreasedinadose-dependentmanner,with10 mMlovastatin
achieving the highest inhibition of viral replication at both 24 and
48 hp.i.TheseresultsareconsistentwiththosepublishedforDENV-
2 strain NewGuinea C[38].
DENV-2 Protein Synthesis is Necessary to Induce ER
Rearrangement and Expansion
We next wondered whether other cellular pathways might be
involved in the rearrangement and expansion of the ER in DENV-
ER Rearrangement by DENV-2 Early after Infection
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drive this ER alteration. We tested these possibilities by examining
whether inhibition of cellular transcription or viral protein
synthesis would abrogate the rearrangement and expansion of
the ER in cells infected with DENV-2. To do this, we first tested
whether treatment of 2fTGH cells with actinomycin D (Act D)
would inhibit the upregulation of GRP78 in the presence of the
ER stress-inducing drug thapsigargin (Tg). Treatment of cells with
Tg has been shown to upregulate transcription and translation of
GRP78 [39]. 2fTGH cells were mock-treated or treated with
1 mMT go r1 0mg/mL Act D or both for 12 h, and levels of
GRP78 were analyzed by immunoblot. As demonstrated in Figure
S3, cells treated with Tg demonstrated elevated levels of GRP78
expression compared to mock-treated or Act D-treated cells. In
contrast, levels of GRP78 remained unchanged in cells that were
co-treated with Tg and Act D. From these results, we concluded
that the Act D concentration and duration of treatment were
adequate for our experiments. We next mock-infected or DENV2-
infected 2fTGH cells for 12 h in the presence or absence of 10 mg/
mL Act D or 50 mg/mL cycloheximide (CHX) at the time of
infection. Cells were fixed and stained for viral proteins E and
NS3. Staining of mock-infected 2fTGH cells that were mock-
treated or treated with Act D (Fig. 6A) or CHX (Fig. 6B)
demonstrated no E or NS3 staining and there was no gross
enlargement of the ER. When we stained for E and NS3
expression in DENV-2 infected cells treated with Act D, we found
them to be expressed (Fig. 6D). Moreover, we found that DENV-2
infected cells treated with Act D had a grossly enlarged ER
(Fig. 6D) similar to DENV-2 infected cells that were mock-treated
(Fig. 6C). In contrast, treatment of DENV-2-infected 2fTGH cells
with CHX resulted in the inhibition of viral protein synthesis and
in the few infected cells where some viral translation occurred, we
observed a drastic reduction in viral protein expression and in the
rearrangement and expansion of the ER (Fig. 6E) compared to
DENV-2-infected 2fTGH cells that were mock-treated (Fig. 6C) or
treated with Act D (Fig. 6D). Increased magnification of DENV-2
infected cells that were mock-treated revealed what appear to be
lamellar stacks (Fig. 6F), and vesicle pore-like openings [5] were
evident in DENV-2-infected cells that were mock-treated (Fig. 6F)
or treated with Act D (Fig. 6G). These data demonstrate that
rearrangement and expansion of the ER during DENV-2 infection
does not require the de novo expression of host genes involved in ER
biogenesis. Moreover, it shows that DENV-2 viral protein
synthesis is necessary to induce rearrangement of the ER.
DENV-2 Induced ER Rearrangement and Expansion
Induces Lipid Droplet Reabsorption
In this study, we have demonstrated that DENV-2-induced ER
rearrangement and expansion proceeds independently of cellular
pathways involved in ER biogenesis. Additionally, our data
demonstrates that DENV viral protein synthesis is sufficient to
drive the rearrangement of preexisting intracellular membranes.
However, the data presented so far do not fully account for the
increased volume of the ER during DENV-2 infection. Given the
sudden cellular demand for lipids after DENV infection and the
non-involvement of the UPR and SREBP-2 pathways, we decided
to investigate whether lipid droplets (LDs) might provide the cell
with a pool of ready-made lipids for the expansion of the ER. LDs
are organelles specialized for the storage of neutral lipids and
regulation of cellular lipid metabolism, and they function as lipid
processing centers that are readily available to the cell [40].
Therefore, we infected 2fTGH cells with DENV-2 for 12 h, fixed
them, and stained for viral proteins E and NS3 and for LDs with
Bodipy 493/503, a dye that specifically targets neutral lipids in
LDs, and processed the cells for LSCM. Uninfected cells showed a
staining pattern characteristic of LDs (Fig. 7A). Interestingly, these
LD spots were not seen in DENV-infected cells; instead, we found
the ER to be stained with the Bodipy 493/503 dye, suggesting the
LD neutral lipids had been reabsorbed into the ER (Fig. 7A). As
with our previous results, staining of E and NS3 viral proteins
colocalized to the grossly enlarged ER of DENV-2 infected cells
and was absent in adjacent non-infected cells (Fig. 7A). In order to
gain more accurate information regarding the spatial localization
of LDs in uninfected cells and the relative rearrangement of the
ER in DENV-2-infected cells, we performed a deconvolution of
the image stacks from Figure 7A and generated three-dimensional
(3-D) views of the deconvoluted data with an iso-surface rendering
based on the LDs stained with Bodipy 493/503. This 3-D image
rendition allows for the visualization of the LDs in the uninfected
cells while also allowing for the visualization of the neutral lipid
staining within the enlarged ER as well as the DENV-2 viral
proteins in the infected cells. In agreement with Figure 7A, LDs
are only found in uninfected cells (Fig. 7B). These results suggest
an early involvement of LDs in the rearrangement and expansion
of the ER.
Discussion
The results presented here for DENV-2 support our first
hypothesis; namely, that viral protein synthesis is sufficient to drive
the early expansion of the ER without inducing increased
transcription and/or translation of resident ER proteins and genes
involved in membrane biogenesis. Early after infection (12 h),
DENV did induce the IRE1-XBP1 pathway of the UPR, but
expression of XBP1 was localized to the ER and not the nucleus.
These data are consistent with our previous results that
demonstrate splicing of the precursor mRNA of Xbp1 as early as
12 h p.i. [26]. Using genetically-deficient cells, we show that the
early DENV-induced ER expansion occurrs independently of the
XBP-1 and ATF6 pathways. Additionally, we demonstrate that
DENV-2 infection at 12 h p.i. does not induce the SREBP-2
pathway or upregulation of HMGCR. Although the data
presented here did not support our second hypothesis that the
induction of cellular stress pathways such as the UPR and lipid
biosynthesis (e.g., SREBP-2) is necessary for rearrangement and
expansion of the ER early after DENV-2 infection, these two
hypotheses are not mutually exclusive in that cellular stress
pathways do play a role as the infection progresses. This
interpretation is consistent with our previous studies, in which
we demonstrated that DENV-2 infection modulates the UPR in a
time-dependent manner by sequentially activating and suppressing
PERK-eIF2a phosphorylation early in infection, followed by the
activation of the IRE1-XBP1 pathway during mid-infection and
then activation of the ATF6 pathway and SREBP-2 pathway late
in infection [26]. The sequential activation of these pathways is
Figure 2. DENV-induced ER rearrangement and expansion is independent of the XBP-1 pathway. XBP1
+/+ (A–D) and XBP1
2/2 (E–H) MEF
cells were infected with DENV-2 for 12 h and stained intracellularly for cellular proteins using antibodies against (A and E) GRP78, (B and F) GRP94, (C)
XBP1, and (G) ATF6 (magenta), followed by secondary antibodies conjugated to Alexa FluorH 647. DENV proteins were detected with mouse MAbs
against DENV E (green) and NS3 (red) directly conjugated to Alexa FluorH 488 and Alexa FluorH 594, respectively. Nuclear staining (blue) was
performed using DAPI stain. Images were acquired and processed as described in Fig. 1. Total magnification 6306.
doi:10.1371/journal.pone.0038202.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38202Figure 3. DENV-induced ER rearrangement and expansion is independent of the ATF6 pathway. ATF6
+/+ (A–C) and ATF6
2/2 (D–F) MEF
cells were infected with DENV-2 for 12 h and intracellularly stained for cellular proteins (A and D) GRP78, (B and E) GRP94, and (C and F) XBP1
(magenta), followed by secondary antibodies conjugated to Alexa FluorH 647. DENV proteins were detected with mouse MAbs against DENV E
(green) and NS3 (red) directly conjugated to Alexa FluorH 488 and Alexa FluorH 594, respectively. Nuclear staining (blue) was performed using DAPI
stain. Images were acquired and processed as described in Fig. 1. Total Magnification 6306.
doi:10.1371/journal.pone.0038202.g003
ER Rearrangement by DENV-2 Early after Infection
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38202further supported by studies with WNVkun, which showed that
HMGCR is upregulated at later times post-infection [35]. We
believe the early rearrangement of the ER provides the virus with
the initial membranous platform necessary to establish a
productive infection and localizes and concentrates preexisting
cellular proteins required for viral translation, replication and
Figure 4. DENV does not induce the SREBP-2 pathway or upreglation of HMGCR early after infection. 2fTGH cells were mock-treated (A)
or treated with DTT (B) for 6 h. Cells were then fixed and stained intracellularly for cellular proteins using antibodies against SREBP-2 (green) and
HMGCR (red) followed by secondary antibodies conjugated to Alexa FluorH 488 and Alexa FluorH 546, respectively. 2fTGH cells were infected with
DENV-2 for 12 h and stained intracellularly for (C) SREBP-2 (magenta) and (D) HMGCR (magenta) followed by secondary antibodies conjugated to
Alexa FluorH 647; mouse MAbs against DENV E (green) and NS3 (red) directly conjugated to Alexa FluorH 488 and Alexa FluorH 594, respectively, were
used to detect DENV proteins. Nuclear staining (blue) was performed using DAPI stain. The multiple-exposure images were captured using a 406/1.4
Plan-Apochromat DIC oil objective on a Zeiss 710 LSM using bandpass filter sets appropriate for DAPI, Alexa FluorH 488, Alexa FluorH 594 and Alexa
FluorH 647 and were processed as previously described in Figure 1. (E) SREBP-2 proteolyic processing by immunoblot analysis. Actin was used as a
loading control. In (F), 2fTGH cells were infected with DENV-2 over a 3–12 h time-course. Lysates were collected and analyzed for SREBP-2 and
HMGCR expression by immunoblot analysis. Actin was used as a loading control, and expression of DENV NS1 was used to confirm viral infection. A
time-matched mock-infected control was included at each time-point. Total magnification 6006.
doi:10.1371/journal.pone.0038202.g004
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38202immune evasion. Not surprisingly, viruses that target the ER have
evolved to take advantage of this organelle to propagate more
effectively [41,42,43,44,45].
Cells infected with a wide range of viruses have been shown to
accumulate rearranged and expanded ER and other cellular
membranes [25]. For the Flaviviridae family of viruses, the
Figure 5. Lovastatin treatment of DENV-infected cells does not inhibit ER rearrangement. Mock-infected 2fTGH cells were treated with
10 mM lovastatin for 12 h and were stained intracellularly for (A) SREBP-2 (green) and HMGCR (red). (B) Cells were also stained for DENV proteins E
(green) and NS3 (red). 2fTGH cells were infected with DENV-2 and mock-treated for 12 h. Cells were fixed and stained intracellularly for (C) SREBP-2
(magenta) and (D) HMGCR (magenta), followed by DENV E (green) and NS3 (red) staining. Nuclear staining (blue) was performed using DAPI. DENV-
infected 2fTGH cells were treated with 10 mM lovastatin at the time of infection and incubated for 12 h. Cells were fixed and stained as described
above for (E) SREBP2 (magenta) and (F) HMGCR (magenta) and DENV E (green) and NS3 (red). Nuclear staining (blue) was performed using DAPI, and
images were acquired as previously described. Total magnification 6306.
doi:10.1371/journal.pone.0038202.g005
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38202Figure 6. DENV-induced ER rearrangement requires viral protein synthesis. Mock-infected 2fTGH cells were (A) treated with 10 mg/mL
actinomycin D (Act D) or (B) treated with 50 mg/mL cycloheximide (CHX), fixed and stained intracellularly for viral proteins E (green) and NS3 (red);
nuclear staining (blue) was performed with DAPI. DENV-infected 2fTGH cells were (C) mock-treated or treated with (D) Act D or (E) CHX at the time of
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38202rearranged and expanded ER is often referred to as convoluted
membranes, paracrystalline arrays, lamellar structures or vesicle
packets [25]. However, little is known as to how proteins encoded
by members of the Flaviviridae family induce rearrangement of the
ER. The NS4A protein of WNVkun and DENV-2 [46,47], as well
as Hepatitis C virus (HCV) NS4B [48], have been shown to induce
ER rearrangement when overexpressed. DENV NS3 protein has
been shown to be associated with the nuclear receptor binding
protein and to induce ER membrane alteration and proliferation
[49]. One study of HCV demonstrated that overexpression of all
viral proteins individually or in combination, with the exception of
NS5A and NS5B, led to distinct membrane alterations, indicating
that both homotypic and heterotypic protein interactions can
modulate membrane rearrangement and expansion [50]. Like-
wise, overexpression of ER-associated proteins are involved in
driving ER rearrangement and expansion [23]. HMGCR, rat
microsomal aldehyde dehydrogenase (msALDH), cytochrome
P450 and cytochrome b, for example, have been shown to form
crystalloid ER, also referred to as organized smooth ER (OSER),
when overexpressed [51,52,53,54]. These OSER-forming proteins
are anchored to the ER via transmembrane domains, and a large
portion of their cytoplasmic domain is exposed. Mutational
analysis of both these domains has been shown to abolish OSER
formation, thus demonstrating that ER localization and homotypic
protein interactions play an important role in rearrangement of
the ER [23]. Our data indicate that synthesis and targeting of viral
proteins early in infection are sufficient to drive the rearrangement
of the ER, presumably via cytoplasmic heterotypic protein
infection. Cells were fixed and stained as in A and B. Figures (F) and (G) are increased magnification of figures C and D, respectively. Black arrows point
to lamellar stack-like structures and white arrows point to vesicle-like pore openings on the enlarged ER. Scale bar =2 mm. Total magnification 6006.
doi:10.1371/journal.pone.0038202.g006
Figure 7. DENV-induced ER expansion induces lipid droplet reabsorption. DENV-2-infected 2fTGH cells were fixed and stained with mouse
MAbs against DENV-2 E-protein (4G2; pseudo-colored green) and NS3 (red). Lipid droplets (LD; pseudo-colored magenta) were stained using Bodipy
493/503 dye. (B) Three-dimensional reconstruction of the rearranged and expanded ER early after DENV-2 infection. The deconvolved image was
rotated 180u on the X-axis relative to Fig. 7A. Images were obtained using a Zeiss 710 LSM as previously described. Z-stack series (61 panels) were
deconvolved using Huygens software (Scientific Volume Imaging), and an iso-surface model was generated using Imaris 7.2 software (Bitplane
Scientific Software). LD (pseudo-color magenta), E (pseudo-color green) and NS3 (red). Total magnification 6006.
doi:10.1371/journal.pone.0038202.g007
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PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e38202interactions. This rearrangement of the ER leads to redistribution
of HMGCR from the outer membrane of the nuclear envelope
and to the clustering of ER-resident proteins along with viral
proteins. The degree of affinity between the cytoplasmic domains
of viral and cellular proteins could explain the different shapes and
sizes of the ER structures that are observed projected in three-
dimensional space during viral infection in this and other studies
[3,4,22,23,25]. We hypothesize that homotypic and heterotypic
protein interactions between viral and cellular proteins drive the
rearrangement of the ER at this early stage in DENV infection.
Recent studies with DENV, JEV, WNVkun and WNVNY99 have
implicated cholesterol to play a major role in viral infection.
Cholesterol depletion with methyl-b-cyclodextrin (MbCD) result-
ed in disruption of lipid rafts on the plasma membrane, effectively
blocking entry of WNVNY99, JEV and DENV-2 [36,37]. Studies
with WNVkun have shown the redistribution of cholesterol from
the plasma membrane to membranous sites of viral replication and
targeting of proteins involved in cholesterol biosynthesis, namely
HMGCR, to these viral replication complexes [35]. However, a
different study with WNVNY99 did not find the cholesterol
biosynthesis pathway to be induced, suggesting that de novo
cholesterol synthesis might not be needed for WNV RNA
replication [37]. In these studies, we find that 12 h p.i, DENV-
2-induced ER rearrangement leads to the redistribution of
HMGCR from the outer membrane of the nuclear envelope,
where it is synthesized and localized [34] to sites of viral
replication, in agreement with previous observations [35].
However, we did not observe activation of SREBP-2 or induction
of HMGCR expression at this early time-point. Furthermore,
when we treated cells with lovastatin to inhibit de novo cholesterol
biosynthesis, we were still able to detect ER membrane
rearrangement and found SREBP-2 to remain inactive but
redistributed and colocalized with viral proteins E and NS3. This
further suggests that initial intracellular cholesterol levels are
sufficient to maintain membrane fluidity and formation of viral
replication sites, in agreement with the results of Medigeshi et al
[37]. Although our studies did not specifically focus on the lipid
biosynthesis pathways, our findings that SREBP-2, also a
transcription activator of fatty acid synthase (FASN) [55,56], is
not induced at this early time-point is also in agreement with
previous studies in which FASN was shown to be redistributed to
sites of viral replication but was not upregulated during DENV
infection [57]. Additionally, our data show that although
treatment with lovastatin does lower infectious viral production
at later time-points, as previously reported [38], rearrangement
and expansion of the ER are still induced in the presence of this
drug, implying that cholesterol is important for viral production,
such as assembly or egress, but not at the step of inducing ER
rearrangement early in DENV-2 infection.
The central of role of LDs has become the focus of many
studies, from the regulation of lipid storage and utilization to
putative involvement in obesity and metabolic diseases such as
insulin resistance, type II diabetes and hepatic steatosis [40].
Studies with hepatitis C virus (HCV) have demonstrated that LDs
and their close association with the ER create a unique
microenvironment that promotes efficient viral replication and
supports persistent viral infection [58]. The HCV Core protein has
been shown to associate with LDs to form a platform for viral
replication and assembly [59]. HCV Core protein expression has
also been shown to modify the distribution of LDs within the cell,
such that they aggregate in the perinuclear area [60,61]. In these
studies, we find that early after DENV infection, LDs are depleted
and reabsorbed into the rearranged and enlarged ER. Depletion
of LDs during DENV-2 infection may be utilized as a source of
ready-made lipids for membrane expansion, prior to subsequent
induction of pathways that respond to ER stress and lipid
biosynthesis. We have previously shown the UPR and SREBP-2
pathway to be induced in a time-dependent manner during
DENV-2 infection [26] consistent with studies on WNVkun
[35,62]. Previous studies have also demonstrated the increase in
LDs, following ER stress, to play a crucial role in sequestering
misfolded proteins and preventing accumulation of lipotoxic non-
esterified fatty acids by allowing their translocation to the cytosol
where there are targeted to the proteasome for degradation [63].
Interestingly, the capsid protein of DENV-2 was recently shown to
associate with LDs and was required for efficient viral replication
[64], while a different study demonstrated that DENV-2 infection
induced autophagy-dependent LD modification at later times
post-infection [65]. In our study, however, the ER-reabsorbed LDs
remained in their neutral state as demonstrated by the neutral lipid
staining with Bodipy. Studies using Huh-7 cells have demonstrated
microsomal triglyceride transfer protein (MTP) to be involved in
the transmembrane transfer of neutral lipids from the cytosol to
the lumen of the ER [55]. How DENV-2 infection induces the
reabsorption of LDs into the ER at these early time-points, and
whether it involves MTP or some other form of lipid exchange
between cytosolic LDs [66] or regression [67], remains to be
further investigated. Nonetheless, our studies suggest an early role
for LDs in the early expansion of the ER during DENV-2
infection.
In conclusion, we have demonstrated that ER rearrangement
and expansion is an early event in the DENV life cycle that is
driven by viral but not host protein synthesis, is independent of the
UPR and SREBP-2 pathways, and likely involves reabsportion of
LDs. Our findings also demonstrate that DENV infection can be
use as a tractable system for studying membrane rearrangement
and LD biology. Lastly, understanding the molecular mechanism
by which DENV-2 is able to hijack host cellular processes will aid
in the discovery of novel anti-viral therapeutic approaches.
Materials and Methods
Cell Lines and Viruses
Humanfibrosarcoma2fTGHcells(kindlyprovidedbyGeorgeR.
Stark, Cleveland Clinic Foundation, Cleveland, OH) [68] were
grown in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco
BRL, Carlsbad, CA), 100 units/ml penicillin, 100 mg/ml strepto-
mycin, and 10% fetal bovine serum (FBS) (HyClone, Logan, UT) at
37uCi n5 %C O 2. Baby hamster kidney cells (BHK-21 clone 15;
kindly provided by S Kliks, San Francisco, CA) [69] were grown in
minimal essential medium-alpha (MEM-a; Gibco BRL), 100 units/
ml penicillin, 100 mg/ml streptomycin, and 10% FBS (HyClone).
Aedes albopictus (C6/36) cells (American Type Culture Collection
[ATCC], Manassas, VA), were grown in Leibovitz’s L-15 medium
(Gibco) with 100 units/ml penicillin, 100 mg/ml streptomycin,
10 mM HEPES, and 10% FBS. XBP1
+/+, XBP1
2/2, ATF6a
+/+,
andATF6a
2/2MEFs(kindgiftfromRandalKaufman,Universityof
Michigan, Ann Arbor, MI) were grown in DMEM, 100 units/ml
penicillin, 100 mg/ml streptomycin, 16non-essential amino acids,
55 mM b-mercaptoethanol, 16glutamax (Gibco), and 10% FBS.
DENV-2strainPL046(kindlyprovidedbyH.-YLei,NationalCheng
KungUniversity,Tainan,Taiwan)wasamplifiedinC6/36cells,and
PFU/ml were determined using BHK cells as previously described
[26].
Chemical Treatment
2fTGH cells were mock-infected or infected with DENV-2
(PL046) at a multiplicity of infection (MOI) of 5 in the presence or
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PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38202absence of increasing doses of lovastatin (0–10 mM). Viral
supernatants were collected at the indicated time-points, and viral
titers were determined. For all confocal imaging experiments,
10 mM lovastatin was added at the time of infection. Thapsigargin
(Sigma Chemical) treatment of 2fTGH cells was performed at a
final concentration of 1 mM thapsigargin for 12 h. 2fTGH
treatment with dithiothreitol (DTT; Sigma Chemical) was
performed at a final concentration of 2 mM for the indicated
times. Cycloheximide (CHX; Sigma Chemical) treatment of
2fTGH cells was performed at the time of infection at a final
concentration of 50 mg/mL.
Immunoblot Analysis
Cell lysates were prepared using RIPA lysis buffer (10 mM Tris-
HCl [pH 7.5], 500 mM NaCl, 1 mM EDTA, 0.5% Na-deoxy-
cholate, 0.1% SDS, and 1% Triton X-100) containing complete
EDTA-free protease inhibitor and phosphatase inhibitors. Equal
amounts of protein, as measured by Bradford assay (Bio-Rad,
Hercules CA), were resolved on a 7% or 11% sodium dodecyl
sulfate-polyacrylamide gel (SDS-PAGE). Proteins were transferred
onto Immobilon-P polyvinylidene fluoride (PVDF) membranes
(Millipore, Billerica, MA). Immunoblots were blocked at room
temperature for 1 h using blocking buffer (16phosphate-buffered
saline pH 7.3 [PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4N7H2O, 1.4 mM KH2PO4], 5% non-fat dry milk, and
0.1% Tween-20).
Primary antibodies were obtained from the following sources
and were diluted in blocking buffer at the following dilutions: anti-
GRP78 (1:1,000), anti-actin-horseradish peroxidase (HRP)
(1:1,000) (Santa Cruz Biotechnologies); anti-SREBP-2 (1:1,000)
(BD Pharmigen); anti-HMG-CoA reductase (1:1,000) (Upstate
Biotechnologies); and anti-NS1 mouse monoclonal antibody
(MAb) 7E11 (1:1,000), which recognizes all four DENV serotypes
(kind gift from Robert J. Putnak, Walter Reed Army Institute of
Research, Washington, DC). The blots were incubated overnight,
washed twice with 16PBS-T (PBS containing 0.1% Tween-20) at
room temperature, and incubated for 1 h with HRP-conjugated
goat anti-rabbit or goat anti-mouse at 1:10,000 or 1:5,000,
respectively. Images were aquired using the Chemi-Doc system
(Bio-Rad).
Confocal Microscopy
2fTGH cells and ATF6
+/+, ATF6
2/2, XBP1
+/+ and XBP1
2/2
MEF cells were seeded at 5610
4 cells/well in a 12-well plate
containing a microscope cover slip in each well and left to adhere
overnight. Cells were infected with DENV-2 at a MOI of 5 for
12 h. Cover slips were washed three times with 16PBS, fixed in
4% formaldehyde for 10 minutes, and washed three times with 16
PBS. Cells were then permeabilized using 0.5% saponin in PBS for
10 minutes. Blocking was performed using 1% BSA in 0.1%
Tween-PBS buffer for 1 h. Primary antibodies were diluted 1:50 in
blocking buffer for 1 h and were obtained from the following
sources: rabbit anti-GRP78, rabbit anti-GRP94, goat anti-ATF6
(N16) and rabbit anti-XBP1 (Santa Cruz Biotechnologies); mouse
anti-SREBP-2 (BD Pharmigen); and rabbit anti-HMG-CoA
reductase (Upstate Biotechnologies). Mouse anti-DENV E (4G2;
ATCC) and mouse anti-NS3 (E1D8; P.R. Beatty and E. Harris,
unpublished) antibodies were directly conjugated to Alexa-488 and
Alexa-594, respectively. Alexa Fluor
TM 488 (goat anti-rabbit),
Alexa Fluor
TM 546 (donkey anti-goat), and Alexa Fluor
TM 647
(goat anti-rabbit) were diluted 1:200 (Molecular Probes, Invitrogen
Corporation, Carlsbad, CA). Cover slips were mounted using
VECTASHIELDH mounting medium with DAPI (Vector Labo-
ratories Burlingame, CA). Images were captured using the 636/
1.25 Plan-Neofluar DIC oil objective on a Zeiss laser-scanning
confocal microscope (LSM) 510 UV/Vis or using a 406/1.4 Plan-
Apochromat DIC oil objective on a Zeiss LSM 710 Meta LSM
(College of Natural Resources Biological Imaging Facility, UC
Berkeley, Berkeley, CA). All images were processed using Photo-
shop CS4 Suites and Zeiss operating software.
To generate the 3D image in Fig. 7B, 2fTGH cells were infected
with DENV-2 and fixed and permeabilized as described above.
Cells were then incubated with mouse MAb against DENV-2 E-
protein overnight. Cells were washed twice with PBS-Tween and
stained with goat anti-mouse secondary antibody conjugated to
Alexa Fluor
TM647 for 1 h. Cells were then washed again and
incubated with mouse anti-NS3 MAb directly conjugated to
Alexa-594 for 1 h, at which time Bodipy 493/503 (Molecular
Probes) was added at a final concentration of 20 mg/mL and
incubated for an additional 15 minutes. Cells were washed and
mounted as described above. Optical slices were acquired at
0.1 mM Z-stacking intervals. These stacks were then deconvoluted
using Huygens Essential Software (Scientific Volume Imaging),
and a three-dimensional image was generated using Imaris 7.2
software (Bitplane Scientific Software).
Supporting Information
Figure S1 Controls for UPR markers in 2fTGH cells.
2fTGH cells were (A) mock-treated or (B) treated with DTT for
12 h, fixed and stained intracellularly for cellular proteins XBP1
(green) and ATF6 (red), followed by secondary antibodies
conjugated to Alexa FluorH 488 and Alexa FluorH 594,
respectively. Mock-infected 2fTGH cells were also treated with
1 mM thapsigargin for 12 h, then stained intracellularly for cellular
proteins (C) GRP78 (magenta) and (D) GRP94 (magenta),
followed by secondary antibodies conjugated to Alexa FluorH
647 and mouse monoclonal antibodies directly conjugated to viral
proteins E (green) and NS3 (red). GRP78 (E) and GRP94 (F)
cellular expression in mock-infected and mock-treated 2fTGH
cells. Images were obtained as previously described in Materials
and Methods. Total magnification 4006.
(TIF)
Figure S2 Lovastatin inhibits infectious DENV viral
production. 2fTGH cells were infected with DENV-2 and
treated with increasing concentrations of lovastatin (0–10 mM) at
the time of infection. Supernatants were collected at the indicated
time-points, and infectious virus production was determined by
plaque assay. Error bars represent +/2 SD; n=3.
(TIF)
Figure S3 Actinomycin D inhibition of thapsigargin-
induced GRP78 expression in 2fTGH cells. 2fTGH cells
were mock-treated or treated with 1 mM thapsigargin (Tg) or
50 mg/mL actinomycin D (Act D) or both for 12 h, and levels of
GRP78 were analyzed by immunoblot analysis as previously
described.
(TIF)
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